Group 1 - UK Prime Minister Starmer will visit China from January 28 to 31, marking the first visit by a UK Prime Minister in eight years. Discussions will focus on bilateral relations and trade investment cooperation [3][6] - US President Trump stated that he is not concerned about the decline of the US dollar, which has recently dropped over 1% to a nearly four-year low of 95.7905 [3][6] - A new wave of price increases is sweeping the global chip industry, with Samsung and SK Hynix significantly raising prices for LPDDR memory used in iPhones by over 80% and nearly 100%, respectively [3][6] Group 2 - Clawdbot has gained significant attention in the tech industry, seen as a precursor to the future of AI agents. Meanwhile, domestic AI models are also gaining traction, with DeepSeek releasing a new OCR model [4] - The Ministry of Human Resources and Social Security announced plans to enhance labor rights for new employment forms and revise paid leave regulations [5] - The National Bureau of Statistics reported that profits of large industrial enterprises in China reached 7.4 trillion yuan in 2025, a 0.6% year-on-year increase, reversing a three-year decline [5] Group 3 - Anta Sports announced a deal to acquire a 29.06% stake in Puma for 15.06 billion euros (approximately 122.8 billion yuan), making Anta the largest shareholder of Puma [9] - The China Fund Industry Association released a performance benchmark database for public funds, focusing on stock indices [9] - The resource product LOF purchase limit has been upgraded, with major funds suspending large purchases starting January 28 [9] Group 4 - Companies such as Guotai Junan and Shenwan Hongyuan expect significant profit increases in 2025, with projected growth rates ranging from 41.76% to 115% [11] - Aisen Co. plans to invest 20 billion yuan in a semiconductor materials manufacturing base in East China [12] - The central bank reported a decrease in real estate loans, with a total balance of 51.95 trillion yuan at the end of 2025, down 963.6 billion yuan year-on-year [12]

三是规范药品经营和使用。完善药品网络销售管理制度，压实药品网络交易第三方平台提供者责任。加 强医疗机构药事管理，保障使用环节药品质量。明确医疗机构配制制剂审批流程，规定医疗机构制剂调 剂使用条件和程序，支持配制儿童用医疗机构制剂，满足儿童患者用药需求。 四是严格药品安全监管。明确药品安全监督检查措施。细化药品质量抽查检验流程，规定当事人对检验 结果有异议的，可以申请复验。针对违法行为设定了严格的法律责任。 二是加强药品生产管理。严格药品委托生产管理，压实委托生产时药品上市许可持有人的责任，明确可 以委托分段生产药品的情形。明确中药饮片、中药配方颗粒生产、销售的管理要求。 新华社北京1月27日电 国务院总理李强日前签署国务院令，公布修订后的《中华人民共和国药品管理法 实施条例》（以下简称《条例》），自2026年5月15日起施行。《条例》共9章89条，修订后的主要内容 如下。 一是完善药品研制和注册制度。支持以临床价值为导向的药品研制和创新，鼓励研究和创制新药，支持 新药临床推广和使用。明确药物非临床安全性评价研究机构资格认定程序，细化药物临床试验管理要 求。设立药品上市注册加快程序，明确药品再注册程序，规定处方 ...

国务院总理李强日前签署国务院令，公布修订后的《中华人民共和国药品管理法实施条例》（以下 简称《条例》），自2026年5月15日起施行。《条例》共9章89条，修订后的主要内容如下。 一是完善药品研制和注册制度。支持以临床价值为导向的药品研制和创新，鼓励研究和创制新药， 支持新药临床推广和使用。明确药物非临床安全性评价研究机构资格认定程序，细化药物临床试验管理 要求。设立药品上市注册加快程序，明确药品再注册程序，规定处方药、非处方药转换机制。对符合条 件的儿童用药品、罕见病治疗用药品给予市场独占期，对含有新型化学成份的药品等进行数据保护。细 化药品上市许可持有人的责任。 四是严格药品安全监管。明确药品安全监督检查措施。细化药品质量抽查检验流程，规定当事人对 检验结果有异议的，可以申请复验。针对违法行为设定了严格的法律责任。 二是加强药品生产管理。严格药品委托生产管理，压实委托生产时药品上市许可持有人的责任，明 确可以委托分段生产药品的情形。明确中药饮片、中药配方颗粒生产、销售的管理要求。 三是规范药品经营和使用。完善药品网络销售管理制度，压实药品网络交易第三方平台提供者责 任。加强医疗机构药事管理，保障使用环节药 ...

来源：新华社 责编：叶舒筠 校对：陶谦 新华社北京1月27日电 国务院总理李强日前签署国务院令，公布修订后的《中华人民共和国 药品管理法实施条例》（以下简称《条例》），自2026年5月15日起施行。《条例》共9章 89条，修订后的主要内容如下。 一是完善药品研制和注册制度。支持以临床价值为导向的药品研制和创新，鼓励研究和创制 新药，支持新药临床推广和使用。明确药物非临床安全性评价研究机构资格认定程序，细化 药物临床试验管理要求。设立药品上市注册加快程序，明确药品再注册程序，规定处方药、 非处方药转换机制。对符合条件的儿童用药品、罕见病治疗用药品给予市场独占期，对含有 新型化学成份的药品等进行数据保护。细化药品上市许可持有人的责任。 二是加强药品生产管理。严格药品委托生产管理，压实委托生产时药品上市许可持有人的责 任，明确可以委托分段生产药品的情形。明确中药饮片、中药配方颗粒生产、销售的管理要 求。 三是规范药品经营和使用。完善药品网络销售管理制度，压实药品网络交易第三方平台提供 者责任。加强医疗机构药事管理，保障使用环节药品质量。明确医疗机构配制制剂审批流 程，规定医疗机构制剂调剂使用条件和程序，支持配制儿童 ...

三是规范药品经营和使用。完善药品网络销售管理制度，压实药品网络交易第三方平台提供者责任。加 强医疗机构药事管理，保障使用环节药品质量。明确医疗机构配制制剂审批流程，规定医疗机构制剂调 剂使用条件和程序，支持配制儿童用医疗机构制剂，满足儿童患者用药需求。 国务院总理李强日前签署国务院令，公布修订后的《中华人民共和国药品管理法实施条例》（以下简称 《条例》），自2026年5月15日起施行。《条例》共9章89条，修订后的主要内容如下。 一是完善药品研制和注册制度。支持以临床价值为导向的药品研制和创新，鼓励研究和创制新药，支持 新药临床推广和使用。明确药物非临床安全性评价研究机构资格认定程序，细化药物临床试验管理要 求。设立药品上市注册加快程序，明确药品再注册程序，规定处方药、非处方药转换机制。对符合条件 的儿童用药品、罕见病治疗用药品给予市场独占期，对含有新型化学成份的药品等进行数据保护。细化 药品上市许可持有人的责任。 二是加强药品生产管理。严格药品委托生产管理，压实委托生产时药品上市许可持有人的责任，明确可 以委托分段生产药品的情形。明确中药饮片、中药配方颗粒生产、销售的管理要求。 四是严格药品安全监管。明确药 ...

Core Viewpoint - The State Council meeting emphasized the importance of national water network construction, cross-border trade facilitation, and the revision of drug management laws to enhance public welfare and economic development [1][2]. Group 1: National Water Network Construction - The national water network is being progressively improved, with key water transport channels and important storage nodes being constructed, which is crucial for optimizing water resource allocation and enhancing flood prevention capabilities [1]. - The construction of the national water network is seen as a strategic measure to ensure national water security and has multiple benefits, including transportation, ecological protection, and tourism [1]. - The government aims to innovate financing mechanisms to attract investments from state-owned enterprises and private capital, ensuring the successful implementation of water network projects [1]. Group 2: Cross-Border Trade Facilitation - Cross-border trade facilitation is identified as a key component of creating a first-class business environment, focusing on efficient logistics and the integration of various transport modes [2]. - The meeting highlighted the need to promote green trade and the development of new business models such as cross-border e-commerce, while optimizing the regulation of special goods [2]. - Enhancements in smart regulatory services, including the development of smart customs and ports, are essential for ensuring quality control of import and export goods [2]. Group 3: Drug Management Law Revision - The revision of drug management laws is crucial for ensuring public safety in medication and promoting the healthy development of the pharmaceutical industry [2]. - The meeting called for improvements in drug research and registration systems, expediting the review and approval of breakthrough therapies to stimulate industry innovation [2]. - Strengthening quality supervision across the entire drug supply chain and cracking down on illegal activities in the pharmaceutical sector are prioritized [2].

Core Viewpoint - The State Council meeting led by Premier Li Qiang emphasized the importance of national water network construction, cross-border trade facilitation, and the revision of key regulations in water supply and drug management to enhance economic growth and public welfare [2][3][4]. National Water Network Construction - The national water network is being progressively improved, with significant advancements in key water transport channels and storage points, which are crucial for optimizing water resource allocation and enhancing flood prevention capabilities [3]. - The construction of the national water network is seen as a strategic measure to ensure national water security and has multiple benefits, including transportation, ecological protection, and tourism [3]. - The government aims to innovate financing mechanisms to attract investments from state-owned enterprises and private capital, ensuring the successful implementation of water network projects [3]. Cross-Border Trade Facilitation - Cross-border trade facilitation is identified as a key component for creating a top-tier business environment, focusing on efficient logistics and multi-modal transport coordination [4]. - The meeting highlighted the need to promote green trade and the development of new business models such as cross-border e-commerce, while optimizing the regulation of special goods [4]. - Enhancements in smart regulatory services and the construction of smart customs and ports are prioritized to ensure efficient and secure trade processes [4]. Water Supply Management - Water supply is recognized as a vital public service, necessitating a coordinated approach to urban and rural water supply development [4]. - The focus is on establishing a comprehensive regulatory system from water sources to end-users, ensuring water quality and safety through updated infrastructure and maintenance [4]. - Water supply units are urged to adhere strictly to regulations and improve operational standards to enhance service quality and emergency management capabilities [4]. Drug Management Regulation - The meeting underscored the importance of timely revisions to drug management laws to ensure public safety and promote a healthy pharmaceutical industry [4]. - There is a push to improve drug research and registration systems, accelerating the approval of breakthrough therapies to stimulate industry innovation [4]. - A strong regulatory framework is to be maintained to oversee the entire drug supply chain, with strict actions against illegal activities in the pharmaceutical sector [4].

Group 1: National Water Network Construction - The national water network construction is a strategic initiative aimed at optimizing water resource allocation, enhancing flood prevention and disaster reduction capabilities, and ensuring national water security. It also has multiple effects including transportation, ecological protection, and tourism [2] - The investment scale for water network projects is large, involving multiple departments and requiring close collaboration. There is a need to accelerate preliminary work, strengthen land and other resource guarantees, and ensure smooth project implementation [2] - Innovative financing mechanisms are necessary to leverage government investment, encourage state-owned enterprises to increase investment, and attract private capital for multi-channel funding [2] Group 2: Cross-Border Trade Facilitation - Cross-border trade facilitation is essential for creating a first-class business environment. Efforts will focus on promoting efficient cross-border logistics, enhancing intermodal transport coordination, and supporting the development of new business models such as green trade and cross-border e-commerce [3] - The establishment of a comprehensive regulatory system for water supply is crucial for public welfare, ensuring both urban and rural water supply development. This includes maintaining water quality and enhancing emergency management capabilities [3] Group 3: Drug Management Regulations - Timely revisions of drug management laws and regulations are important for ensuring public safety in medication and promoting the healthy development of the pharmaceutical industry. This includes improving drug research and registration systems and expediting the review and approval of breakthrough therapies [4] - Maintaining a high-pressure regulatory environment in the pharmaceutical sector is necessary to strengthen quality supervision across the entire supply chain and combat illegal activities [4]